Related references
Note: Only part of the references are listed.A comparative study on interactions of cisplatin and ruthenium arene anticancer complexes with metallothionein using MALDI-TOF-MS
Guangxue Zhang et al.
INTERNATIONAL JOURNAL OF MASS SPECTROMETRY (2011)
Comparative hydrolysis and plasma protein binding of cis-platin and carboplatin in human plasma in vitro
Melani Sooriyaarachchi et al.
METALLOMICS (2011)
Novel insights into the bottom-up mass spectrometry proteomics approach for the characterization of Pt-binding proteins: The insulin-cisplatin case study
Estefania Moreno-Gordaliza et al.
ANALYST (2010)
Proteomic and Metallomic Strategies for Understanding the Mode of Action of Anticancer Metallodrugs
Chiara Gabbiani et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2010)
Unwinding of zinc finger domain of DNA polymerase I by cis-diamminedichloroplatinum(II)
Leila Maurmann et al.
DALTON TRANSACTIONS (2010)
The mechanism of action of platinum anticancer agents-what do we really know about it?
Dan Gibson
DALTON TRANSACTIONS (2009)
Structure, Properties, and Engineering of the Major Zinc Binding Site on Human Albumin
Claudia A. Blindauer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Zinc finger proteins as templates for metal ion exchange: Substitution effects on the C-finger of HIV nucleocapsid NCp7 using M(chelate) species (M = Pt, Pd, Au)
Queite A. de Paula et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2009)
Inhibition of transcription by platinum antitumor compounds
Ryan C. Todd et al.
METALLOMICS (2009)
Albumin as a zinc carrier: properties of its high-affinity zinc-binding site
Jin Lu et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2008)
Characterisation of Cisplatin Binding Sites in Human Serum Proteins Using Hyphenated Multidimensional Liquid Chromatography and ESI Tandem Mass Spectrometry
Joanna Will et al.
CHEMMEDCHEM (2008)
Antitumour metal compounds: more than theme and variations
Michael A. Jakupec et al.
DALTON TRANSACTIONS (2008)
Characterization of platinum anticancer drug protein-binding sites using a top-down mass spectrometric approach
Christian G. Hartinger et al.
INORGANIC CHEMISTRY (2008)
Atomic (HPLC-ICP-MS) and molecular mass spectrometry (ESI-Q-TOF) to study cis-platin interactions with serum proteins
Diego Esteban-Fernandez et al.
JOURNAL OF ANALYTICAL ATOMIC SPECTROMETRY (2008)
Reaction of Zn7Metallothionein with cis- and trans-[Pt(N-donor)2Cl2] anticancer complexes:: trans-PtII complexes retain their N-donor ligands
Markus Knipp et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
The resurgence of platinum-based cancer chemotherapy
Lloyd Kelland
NATURE REVIEWS CANCER (2007)
Direct cellular responses to platinum-induced DNA damage
Yongwon Jung et al.
CHEMICAL REVIEWS (2007)
Interactions of antitumor metallodrugs with serum proteins: Advances in characterization using modern analytical methodology
Andrei R. Timerbaev et al.
CHEMICAL REVIEWS (2006)
Cellular processing of platinum anticancer drugs
D Wang et al.
NATURE REVIEWS DRUG DISCOVERY (2005)
Platinum-intercalator conjugates: From DNA-targeted cisplatin derivatives to adenine binding complexes as potential modulators of gene regulation
H Baruah et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2004)
Kinetic study on the reaction of cisplatin with metallothionein
D Hagrman et al.
DRUG METABOLISM AND DISPOSITION (2003)
Interdomain zinc site on human albumin
AJ Stewart et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Dramatic 5′-residue effect on conformer distribution of short oligonucleotide retro models of the cisplatin-DNA cross-link:: Implications for the Lippard and cross-link distorted base pair steps present in cisplatin-DNA duplex adducts
ST Sullivan et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2002)
Slowing of cisplatin aquation in the presence of DNA but not in the presence of phosphate: Improved understanding of sequence selectivity and the roles of monoaquated and diaquated species in the binding of cisplatin to DNA
MS Davies et al.
INORGANIC CHEMISTRY (2000)
Share Paper
